Additionally, because a bioinformatics analysis of databases found higher amplification frequencies in breast cancer, we evaluated SEPHS2 expression in two TNBC cell lines (MDA-MB231 and MDA-MB468) and TNBC patients to elucidate whether this protein could be correlated with the initiation and progression of this breast cancer subtype. Here, SEPHS2 is linked to breast carcinoma.